Use of polymerase chain reaction (PCR) in leprosy research

Indian Journal of Leprosy

Volumn 71, Issue 1, 1999, Pages 101-110

  Santos, A R ^a   Degrave, W M ^a   Suffys, P N ^a  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

CLOFAZIMINE; DAPSONE; RIFAMPICIN;

CONFERENCE PAPER; DIAGNOSTIC VALUE; DISEASE CONTROL; GENE AMPLIFICATION; INCIDENCE; LEPROSY; MYCOBACTERIUM LEPRAE; NONHUMAN; NOSE SECRETION; POLYMERASE CHAIN REACTION; SKIN BIOPSY;

GENETIC TECHNIQUES; HUMANS; LEPROSY; POLYMERASE CHAIN REACTION; RESEARCH;

EID: 0032805857     PISSN: 02549395     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (35)

1. Abe M, Minigawa F, Yoshino Y et al 1980. Fluorescent leprosy antibody absorption (FLA-ABS) test for detecting subclinical infection with Mycobacterium leprae. Int J Lepr 48: 109-119.
2. Becx-Bleumink 1994. Success of the WHO multidrug therapy, Trop Geogr Med 46: 61-64.
3. Chatterjee G, Kaur S, Sharrna VK et al 1989. Bacillaemia in leprosy and effect of multidrug therapy. Lepr Rev 60: 197-201.
4. Cho SN, Yanogihara DL, Hunter SW et al 1983. Serological specificity of phenolic glycolipid-I from Mycobacterium leprae and its use in serodiagnosis of leprosy. Infect Immun 51: 1077-1083.
5. Clark-Curtiss JE, Docherty MA 1989. A species-specific repetitive sequence in Mycobacterium leprae DNA. J Infect Dis 159: 7-15.
6. Davey TF, Rees RJW 1974. The nasal discharge in leprosy: clinical and bacteriological aspects. Lepr Rev 45: 121-134.
7. Desikan KV, Iyer CGS 1972. The distribution of Mycobacterium leprae in different structures of the skin. Lepr Rev 43: 30-37.
8. DeWit MYL, Douglas JD, McFaden J, Klatser PR 1993. Polymerase chain reaction for detection of Mycobacterium leprae in nasal swabs specimens. J Clin Microbiol 31: 502-506.
9. DeWit MYL, Faber WR, Kreig SR et al 1991. Application of the polymerase chain reaction for the detection of Mycobacterium leprae in skin tissues. J Clin Microbiol 29: 906-910.
10. Godal T, Negassi K 1973. Subclinical infection in leprosy. Brit Med J 3: 557-559.
11. Hartskeerl RA, DeWit MYL, Klatser PR 1989. Polymerase chain reaction for the detection of Mycobacterium leprae. J Gen Microbiol 135: 2357-2364.
12. Hastings RC, 1985. Leprosy. ed RC Hastings, Edinburgh, Churchill Livingstone.
13. Hatta M, Van Beers SM, Madjid B 1995. Distribution and persistence of Mycobacterium leprae nasal carriage among a population in which leprosy is endemic in Indonesia. Trans Royal Soc Trop Med Hyg 89: 381-385.
14. Klatser PR, Van Beers S, Madjid B 1993. Detection of Mycobacterium leprae. Nasal carriers in populations for which leprosy is endemic. J Clin Microbiol 31: 2947-2951.
15. Noordeen SK 1966. Leprosy. Maharashtra Med J 13: 133.
16. Pattyn SR 1994. Future trends in the treatment of leprosy. Trop Geogr Med 46: 85-88.
17. Pattyn SR, Ursi D, Leven M et al 1993. Detection of Mycobacterium leprae by the polymerase chain reaction in nasal swabs of leprosy patients and their contacts. Int J Lepr 61: 389-393.
18. Pearson JMH, Rees RJW, Waters MFR 1975. Sulphone resistance in leprosy. Lancet ii: 69-72.
19. Plikaytis BB, Gelber RH, Shinnick TM 1990. Rapid and sensitive detection of amplification assay of Mycobacterium leprae using nested-primer gene. J Clin Microbiol 28: 1913-1917.
20. Santos AR, De Miranda AB, Sarno EN et al 1993. Use of PCR-mediated amplification of Mycobacterium leprae DNA in different types of clinical samples for the diagnosis of leprosy. J Med Microbiol 39: 298-304.
21. Santos AR, Goes Filho JT, Nery et al 1995. Evaluation of PCR-mediated amplification in non-invasive biological specimens for subclinical detection of Mycobacterium leprae. FEMS Immunol Med Microbiol 504: 113-120.
22. Santos AR, Nery JAC, Duppre NC 1997. Use of the polymerase chain reaction in the diagnosis of leprosy. J Med Microbiol 46: 170-172.
23. Shepard CC 1960. Experimental disease that follows the injection of human leprosy bacilli into foot-pads of mice. J Exp Med 112: 445-454.
24. Sreevatsa, Desikan KV 1988. Screening of drug-resistant strains of M. leprae in lepromatous leprosy patients under multidrug treatment. Indian J Med Res 87: 139-143.
25. THELEP 1987. The THELEP controlled clinical trials. Int J Lepr 55 (Suppl): 864-868.
26. Van Brakel WH, DE Soldenhoff R, McDougal AC 1992. The allocation of leprosy patients into paucibacillary and multibacillary groups for multidrug therapy, taking into account the number of body areas affected by skin or skin and nerve lesions. Lepr Rev 63: 231-246.
27. Waters MFR, Rees RJW, McDougal AC, Weddell AGM 1974. Ten years of dapsone in lepromatous leprosy: clinical, bacteriological and histological assessment and findings of viable leprosy bacilli. Lepr Rev 45: 288-298.
28. Waters MFR 1981. Leprosy. Brit Med J 283: 1321.
29. WHO 1982. WHO Study Group on Chemotherapy of Leprosy for Control Programs. Tech Rep Ser 675.
30. WHO 1985. Epidemiology of leprosy in relation to control. Report of WHO Study Group. Tech Rep Ser 716, pp 11, 21, 26, 29.
31. WHO 1988a. WHO Expert Committee on leprosy.. Sixth Report. Tech Rep Ser 768.
32. WHO 1988b. WHO/Lep/98.2. Action programme for the Elimination of Leprosy. Status Report, Geneva, World Health Organization.
33. WHO 1997. Lep/97.7 1997. A guide to eliminating leprosy as a public health problem. Geneva, World Health Organization.
34. Williams DL, Gillis TP, Booth RJ et al 1990. The use of a specific DNA probe and polymerase chain reaction for the detection of Mycobacterium leprae. J Infec Dis 62: 193-200.
35. Wood AS, Cole ST 1989. A rapid method for the detection of potentially viable Mycobacterium leprae in human biopsies: a novel application of PCR. FEMS Micrbiol Lett 65: 305-310.